ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Westlake Water Treatment Systems Help Pennsylvania Borough Meet U.S. Clean Water Act

The Water Treatment division of Westlake Chemical Corporation (NYSE: WLK), manufacturer of the Accu-Tab® chlorination and CleanSlate® dichlorination systems, today published a new case history outlining the key roles its water treatment systems perform within a recently upgraded wastewater processing plant in Southwestern Pennsylvania.

Close to $50 million was invested by the borough in new construction and retrofits to the Combined Sewer Overflow (CSO) complex located in Donora, Penn. The processing plant, run by the Mon Valley Sewage Authority, now better protects surrounding rivers and streams throughout the region from storm sewage run-off contamination. The Mon Valley project is one of the first in the country to comply with the United States Clean Water Act mandating the reduction or elimination of sewer overflows. It is the largest CSO of its kind in the nation to use Westlake’s solid forms of chlorine and dichlorination chemicals and delivery technologies, which are marketed under the Accu-Tab brand from Axiall Water Treatment, a Westlake business.

Most processing plants in the United States, and the infrastructures that feed them, were built decades ago. As the population and industries grew so did demand loads on these wastewater treatment facilities. Consequently, many are not equipped to process excess wastewater that accompanies heavy rainstorms. This is when overflows typically occur that may result in untreated water being discharged into rivers and streams.

The Accu-Tab chlorination system, which uses United States Environmental Protection Agency (EPA) certified and National Sanitization Foundation (NSF) Standard 60 and 61 listed Accu-Tab White SI calcium hypochlorite tablets and feed equipment, was selected as the primary treatment chlorination chemical based on its low cost and easier maintenance when compared to ultraviolet light systems. The longer shelf-life of Accu-Tab chlorine tablets also made the Accu-Tab system a clear choice over liquid chlorine, which degrades faster. Shelf-life is particularly important because rainstorms are an infrequent occurrence, and the reliable strength of the chlorine to treat the influent water is crucial. At the end of the process, Westlake’s CleanSlate® dechlorination system removes residual chlorine before the water is discharged back into the environment.

“Municipalities and townships that are struggling with how to address their own CSO shortfalls will find valuable information and insights in the Mon Valley project case history. The management at the Mon Valley Sewage Authority and their community took a forward-thinking approach to improving their wastewater processes that not only addressed their current combined sewer processing system needs, but one that also looked many years down the road as well,” said Noel Irizarry, Westlake vice president Chlor-Alkali & Derivatives.

To view the Mon Valley CSO case history, see https://accu-tab.com/MonValleyCSO

About Westlake:

Westlake is a global manufacturer and supplier of materials and innovative products that enhance life every day. Headquartered in Houston, we provide the building blocks for vital solutions — from packaging and healthcare products to automotive and consumer goods, to building and construction products. For more information, visit the company's web site at www.westlake.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.